Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by V Lazaro
Predicting Post-Amnog Rebate Outcomes for Oncology Drugs
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Time to Reimbursement for Oncology Drugs in EU5
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Employment Outcomes for Recent Canadian Radiation Oncology Graduates
Current Oncology
Oncology
ReDO_DB: The Repurposing Drugs in Oncology Database
ecancermedicalscience
Cancer Research
Oncology
Potential Repurposing of Oncology Drugs for the Treatment of Alzheimer's Disease
BMC Medicine
Medicine
Diagnostic Biomarkers for Predicting Adverse Early Pregnancy Outcomes
BJOG: An International Journal of Obstetrics and Gynaecology
Gynecology
Obstetrics
Php293 - Orphan Drugs in Germany - Lessons Learned From Amnog, Best and Worst Practices and Strategic Implications
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Is the Proof of an Additional Benefit Under Amnog in Germany More Difficult for Certain Drugs Than for Other Ones?
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Reimbursement Decisions in Oncology Drugs: An International Analysis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Towards Predicting Post-Editing Productivity
Machine Translation
Linguistics
Artificial Intelligence
Language
Software